city New Delhi India covid-19 infection patient Coronavirus city New Delhi India

Strides Pharma to soon start clinical trials on potential covid-19 drug

Reading now: 957
www.livemint.com

NEW DELHI: Strides Pharma Science Ltd will soon start its own clinical trial of potential covid-19 drug favirpiravir, becoming only the second firm in India to conduct a study on the broad-spectrum antiviral’s use in treating the fatal respiratory disease after Glenmark Pharmaceuticals Ltd. “We have the approval (from Drug Controller General of India) to conduct human study and we will be starting the studies soon," Strides Pharma founder and non-executive chairman Arun Kumar said on a post-earnings conference call on Thursday.

While Kumar said apex drug regulator, DCGI V.G. Somani, has approved the clinical trial, he did not give details on the number of sites that the trial will be conducted, or when it will start.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA